Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine

scientific article published on 15 January 2019

Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1111435578
P356DOI10.1186/S12950-018-0202-Y
P2888exact matchhttps://scigraph.springernature.com/pub.10.1186/s12950-018-0202-y
P932PMC publication ID6332898
P698PubMed publication ID30675131

P50authorTrevor T. HanselQ100503676
Carlo Alberto VoltaQ42186412
Ryan S ThwaitesQ56704841
P2093author name stringGaetano Caramori
Riccardo Ragazzi
Savino Spadaro
Tommaso Mauri
Paolo Ruggeri
Tanushree Tunstall
Mirae Park
Cecilia Turrini
P2860cites workAcute Respiratory Distress SyndromeQ88731683
IFITM3 restricts the morbidity and mortality associated with influenzaQ24369689
HMDB 3.0--The Human Metabolome Database in 2013Q24595162
Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adultsQ26471429
A Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress SyndromeQ26765351
Metabolomics and Its Application to Acute Lung DiseasesQ26765930
Clinical utility of biomarkers of endothelial activation in sepsis--a systematic reviewQ26823450
Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injuryQ28566123
Acute respiratory distress syndrome: the Berlin DefinitionQ29615138
Incidence and outcomes of acute lung injuryQ29615139
The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordinationQ29617876
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.Q30381573
Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injuryQ30425088
Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-AnalysisQ30572421
Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trialsQ30826105
Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injuryQ33512670
Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patientsQ33531552
Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndromeQ33750995
Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injuryQ33808300
Neuromuscular blockers in early acute respiratory distress syndromeQ34023977
Anti-TNFα therapy in inflammatory lung diseasesQ39392448
Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy.Q39499760
Keratinocyte growth factor and hepatocyte growth factor in bronchoalveolar lavage fluid in acute respiratory distress syndrome patientsQ39543512
Urinary Glycosaminoglycans Predict Outcomes in Septic Shock and Acute Respiratory Distress SyndromeQ39960097
Whole blood microRNA markers are associated with acute respiratory distress syndromeQ40063802
Generalizable Biomarkers in Critical Care: Toward Precision MedicineQ40210673
Endothelial Permeability and Hemostasis in Septic Shock: Results From the ProCESS TrialQ40363013
Relationship Between Alternative Resuscitation Strategies, Host Response and Injury Biomarkers, and Outcome in Septic Shock: Analysis of the Protocol-Based Care for Early Septic Shock StudyQ40375039
Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illnessQ42659568
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot studyQ42676967
SuPAR and PAI-1 in critically ill, mechanically ventilated patientsQ43480378
Urine hydrogen peroxide during adult respiratory distress syndrome in patients with and without sepsisQ43556678
Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress SyndromeQ44663643
Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile.Q46068220
External validation of a biomarker and clinical prediction model for hospital mortality in acute respiratory distress syndromeQ46081480
Biomarkers of ARDS: what's new?Q46126147
Significance of von Willebrand factor in septic and nonseptic patients with acute lung injuryQ47333615
Multicohort Analysis of Whole-Blood Gene Expression Data Does Not Form a Robust Diagnostic for Acute Respiratory Distress SyndromeQ47644676
An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome.Q47906121
Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injuryQ47934955
Receptor for advanced glycation end-products is a marker of type I lung alveolar cellsQ47981118
The Prognostic Value of Plasma MicroRNA-155 and MicroRNA-146a Level in Severe Sepsis and Sepsis-Induced Acute Lung Injury PatientsQ47981205
KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome.Q48028199
Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress SyndromeQ48192606
MicroRNAs as biomarkers of acute lung injury.Q49729361
Diagnosis of acute respiratory distress syndrome by exhaled breath analysis.Q50048226
Clinical, technological, and economic issues associated with developing new lung surfactant therapeutics.Q52621637
Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS.Q52633061
Recent advances in understanding acute respiratory distress syndrome.Q52641500
Unsupervised Analysis of Transcriptomics in Bacterial Sepsis Across Multiple Datasets Reveals Three Robust Clusters.Q52656196
Stability of ARDS subphenotypes over time in two randomised controlled trials.Q52686665
Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment.Q52691987
Cellular therapies and stem cell applications in trauma.Q54262549
Fibrinolysis in critically ill patientsQ69223339
Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcomeQ73168001
Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDSQ73251052
Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failureQ73833226
Vascular endothelial growth factor in epithelial lining fluid of patients with acute respiratory distress syndromeQ80867264
The acute respiratory distress syndromeQ84693193
Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsiesQ87105333
Acute respiratory distress in adultsQ34051677
Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major traumaQ34147463
Metabolic consequences of sepsis-induced acute lung injury revealed by plasma ¹H-nuclear magnetic resonance quantitative metabolomics and computational analysisQ34502201
Efficacy and safety of corticosteroids for persistent acute respiratory distress syndromeQ34515095
Comparison of two fluid-management strategies in acute lung injuryQ34528886
Rosuvastatin for sepsis-associated acute respiratory distress syndromeQ34559446
Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsisQ34571235
Update in acute respiratory distress syndromeQ34711754
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trialQ34979725
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trialQ35003693
Plasma surfactant protein levels and clinical outcomes in patients with acute lung injuryQ35535573
Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studiesQ35672843
Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literatureQ35823842
Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injuryQ35855126
Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesisQ35944590
Inflammasome-regulated cytokines are critical mediators of acute lung injuryQ36026253
Platelets in the pathogenesis of acute respiratory distress syndromeQ36237204
ARDS and diffuse alveolar damage: a pathologist's perspectiveQ36502837
The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS) associated with critical illnessQ36616721
Impact of Initial Central Venous Pressure on Outcomes of Conservative Versus Liberal Fluid Management in Acute Respiratory Distress SyndromeQ36689466
Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patientsQ36917451
Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial DesignQ37213606
An integrated clinico-metabolomic model improves prediction of death in sepsisQ37584419
Genetic heterogeneity and risk of acute respiratory distress syndrome.Q38128254
Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis*.Q38155405
Biomarkers in acute respiratory distress syndrome.Q38168021
Biological therapies in the acute respiratory distress syndromeQ38202165
Applying metabolomics to uncover novel biology in ARDS.Q38204194
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 CountriesQ38395601
Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis.Q38431642
Characteristics of microRNAs and their potential relevance for the diagnosis and therapy of the acute respiratory distress syndrome: from bench to bedsideQ38674607
Novel translational approaches to the search for precision therapies for acute respiratory distress syndromeQ38700713
Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?Q38775825
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectacute respiratory distress syndromeQ344873
biomarkerQ864574
P304page(s)1
P577publication date2019-01-15
P1433published inJournal of InflammationQ15757699
P1476titleBiomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine
P478volume16

Reverse relations

cites work (P2860)
Q89585653A personalized approach to the acute respiratory distress syndrome: recent advances and future challenges
Q99407989Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA
Q91742889Causality assessment of adverse events following immunization: the problem of multifactorial pathology
Q92017341Development of a biomarker mortality risk model in acute respiratory distress syndrome
Q90320152Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers
Q90217783Discovering Causal Mechanistic Pathways in Sepsis-associated Acute Respiratory Distress Syndrome
Q64107664Heterogeneity of regional inflection points from pressure-volume curves assessed by electrical impedance tomography
Q89530759R-spondin 2 mediates neutrophil egress into the alveolar space through increased lung permeability
Q104569248Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury
Q96772639The Acute Respiratory Distress Syndrome Biomarker Pipeline: Crippling Gaps between Discovery and Clinical Utility
Q94953191The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: a sentinel?

Search more.